Worlds Largest Online Wholesaler of cannabis invests in Australia’s fastest growing medical cannabis company .
Medicinal Organic Cannabis Australia (MOCA) Pty Ltd is backed by the world’s largest online cannabis wholesaler, OrganicMarijuana.com, are assisting MOCA to fund its expansion operations in Australia and New Zealand.
Research & News
Cannabinoid compounds may inhibit growth of colon cancer cells
While the compounds most commonly associated with cannabis -- THC and CBD -- showed little to no effect, 10 other compounds were effective at inhibiting cancer cell growth. Date: February 06, 2019
Medical marijuana has gained attention in recent years for its potential to relieve pain and short-term anxiety and depression. Now, Penn State College of Medicine researchers say some cannabinoid compounds may actually inhibit the growth of colon cancer cells in the lab. Read More
Under review by the Italian Military
The four companies now under review by the Italian Military are Tilray, Medicinal Organic Cannabis Australia, Aurora and Canopy Growth. The companies in the tender are all required to submit additional information to the Italian Ministry of Defence. The four finalists in the tender have until Friday the 12th of July to meet all outstanding matters Read More
Rise in medical cannabis trade marks in Australia
February 25, 2019
Legalising access to medical cannabis has had a flow on effect on the Australian Trade Marks Register with now 240 pending and registered trade marks claiming the term ‘cannabis.’
In Australia, traders have secured trade mark registrations containing the words cannabis, hemp and cannabis leaf devices. Read More
Starbucks could be the first big chain to launch cannabis drinks
February 25, 2019
Cowen estimates the market for non-psychoactive cannabidiol products will conservatively generate more than US$16 billion in retail sales by 2025.
Starbucks Corp. (SBUX) could be the first fast-food chain to roll out cannabis-infused drinks, according to analysts at Cowen. Although, it may be awhile before customers sip CBD-laced lattes from the Seattle-based caffeine giant. Read More
Investment Bank Predicts $130 Billion Cannabis Market by 2029
February 25, 2019
Last week ended with wealth advisor Pepper International telling CNBC’s “Squawk Box Europe” that the cannabis industry was a wise, sound investment and this week begins with a financial report that backs up that assertion. Hardly a day goes by without some type of industry news that demonstrates positive political momentum, a major milestone, or a huge business deal. . Read More
THC found more important for therapeutic effects in cannabis than originally thought
Researchers measure product characteristics and associated effects with mobile app. Date: February 26, 2019
Source: University of New Mexico. Summary: Researchers recently solved a major gap in scientific literature by using mobile software technology to measure the real-time effects of actual cannabis-based products used by millions of people every day. Read More
Taranaki's medical cannabis crowdfunder raises $1.8 million
A medicinal cannabis start-up based in Taranaki raised almost $2m in its crowdfunding campaign. Date: Feb 15 2019
A medicinal cannabis start-up based in Taranaki raised almost $2m in its crowdfunding campaign. In December, Normanby-based Greenfern Medicinal Marijuana Limited (GMM) started a crowdfunding campaign to secure financial support for its fledgling foray into the medical cannabis market. Read More
“Only a matter of time”
Greens to push Labor hard on cannabis legalisation, citing $2 billion opportunity. Date: February 20, 2019
Greens leader Richard Di Natale is seen at the Melbourne Free Cannabis Community 420 Rally held at Flagstaff Gardens in Melbourne on Friday, April 20, 2018. The legalisation of cannabis will be front and centre of the Australian Greens’ campaign in this year’s upcoming federal election as the party urges Labor to lead the charge on pro-marijuana legislation. Read More
The Potential Clinical Implications and Importance of Drug Interactions Between Anticancer Agents and Cannabidiol in Patients With Cancer
The objective of this review was to identify and examine the pharmacokinetic and pharmacodynamic interactions between cannabidiol (CBD)-only products, such as CBD oil, and anticancer agents. Date: February 18, 2019
A literature search of PubMed (1980 to September 2018) and the Cochrane Collection (1980 to September 2018) was performed using the following search terms: “cannabidiol,” “cancer,” “cannabis,” “marijuana,” and “interaction". Read More
Patient Access June 19
Patient access figures for June 2019 just released - 1,576 SAS-B approvals in June. That's another ~200 over May, bringing the 2019 running total up to 6,502.
Approvals by Age
Here are all the SAS-B approvals from Nov-17 to May-19 by age range of patient. Not surprising to see the 45-65 year olds leading the charge!